Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
24 11 2022
Historique:
pubmed: 9 11 2022
medline: 26 11 2022
entrez: 8 11 2022
Statut: ppublish

Résumé

Soluble adenylyl cyclase (sAC: ADCY10) is an enzyme involved in intracellular signaling. Inhibition of sAC has potential therapeutic utility in a number of areas. For example, sAC is integral to successful male fertility: sAC activation is required for sperm motility and ability to undergo the acrosome reaction, two processes central to oocyte fertilization. Pharmacologic evaluation of existing sAC inhibitors for utility as on-demand, nonhormonal male contraceptives suggested that both high intrinsic potency, fast on and slow dissociation rates are essential design elements for successful male contraceptive applications. During the course of the medicinal chemistry campaign described here, we identified sAC inhibitors that fulfill these criteria and are suitable for

Identifiants

pubmed: 36346696
doi: 10.1021/acs.jmedchem.2c01133
pmc: PMC9866367
mid: NIHMS1865332
doi:

Substances chimiques

Adenylyl Cyclases EC 4.6.1.1
ADCY10 protein, human EC 4.6.1.1
Contraceptive Agents, Male 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15208-15226

Subventions

Organisme : NICHD NIH HHS
ID : F31 HD105363
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD100549
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061290
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY025810
Pays : United States

Références

Pharmacol Ther. 2018 Oct;190:173-186
pubmed: 29807057
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2610-20
pubmed: 25066614
Science. 2000 Jul 28;289(5479):625-8
pubmed: 10915626
SLAS Discov. 2017 Oct;22(9):1168-1174
pubmed: 28426937
J Chem Inf Model. 2019 Jun 24;59(6):2776-2784
pubmed: 31046267
J Mol Biol. 2006 Sep 29;362(4):623-39
pubmed: 16934836
J Biol Chem. 2003 May 2;278(18):15922-6
pubmed: 12609998
Bioorg Med Chem Lett. 2019 Nov 1;29(21):126641
pubmed: 31526603
Biol Reprod. 2020 Aug 4;103(2):145-146
pubmed: 32701150
J Gen Physiol. 2016 Oct;148(4):325-39
pubmed: 27670898
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Development. 2003 Apr;130(7):1317-26
pubmed: 12588848
Drug Discov Today. 2017 Jun;22(6):896-911
pubmed: 28412474
J Synchrotron Radiat. 2012 May;19(Pt 3):442-9
pubmed: 22514183
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3727-32
pubmed: 24567411
J Ocul Pharmacol Ther. 2017 Oct;33(8):574-581
pubmed: 28686538
Yakugaku Zasshi. 1995 Mar;115(3):213-20
pubmed: 7738779
Dev Cell. 2005 Aug;9(2):249-59
pubmed: 16054031
Acta Pharm Sin B. 2018 Sep;8(5):721-732
pubmed: 30245961
J Biol Chem. 2011 Dec 2;286(48):41353-41358
pubmed: 21994938
J Med Chem. 2020 Jun 25;63(12):6315-6386
pubmed: 32182061
Sci Signal. 2018 Nov 06;11(555):
pubmed: 30401788
Nat Chem Biol. 2015 Jul;11(7):525-31
pubmed: 26006010
J Biol Chem. 2013 Nov 15;288(46):33283-91
pubmed: 24100033
ACS Cent Sci. 2019 Sep 25;5(9):1614-1624
pubmed: 31572788
Expert Opin Drug Discov. 2021 Dec;16(12):1441-1451
pubmed: 34210223
Nat Chem Biol. 2015 Jun;11(6):416-23
pubmed: 25894085
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2533-4
pubmed: 25308880
Mol Hum Reprod. 2021 Sep 1;27(9):
pubmed: 34463764
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Interface Focus. 2021 Apr 6;11(2):20200034
pubmed: 33633833
Pharm Sci Technol Today. 2000 Sep 1;3(9):310-317
pubmed: 10996572
Dev Biol. 2006 Aug 15;296(2):353-62
pubmed: 16842770
Biol Reprod. 2020 Aug 4;103(2):176-182
pubmed: 32307523
Anal Biochem. 2011 Sep 15;416(2):206-10
pubmed: 21669181
Adv Cyclic Nucleotide Res. 1979;10:35-55
pubmed: 222124
Hum Reprod. 2019 Jun 4;34(6):1155-1164
pubmed: 31119281
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2535-47
pubmed: 25193033
ACS Med Chem Lett. 2021 Jul 14;12(8):1283-1287
pubmed: 34413957
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Mol Cell Endocrinol. 2018 Jun 15;468:111-120
pubmed: 29146556
Physiol Rev. 2022 Apr 1;102(2):815-857
pubmed: 34698552
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Curr Drug Metab. 2017;18(6):556-565
pubmed: 28302026
J Cell Biol. 2004 Feb 16;164(4):527-34
pubmed: 14769862
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2993-8
pubmed: 14976244
ACS Med Chem Lett. 2020 Mar 26;11(6):1205-1212
pubmed: 32551002
Acta Crystallogr F Struct Biol Commun. 2014 Apr;70(Pt 4):467-9
pubmed: 24699740
Nat Chem Biol. 2016 Oct;12(10):838-44
pubmed: 27547922
Chem Pharm Bull (Tokyo). 2013;61(12):1228-38
pubmed: 24292785
J Am Chem Soc. 2015 Feb 25;137(7):2695-703
pubmed: 25625324
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2555-60
pubmed: 24907564

Auteurs

Michael Miller (M)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

Thomas Rossetti (T)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Jacob Ferreira (J)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Lubna Ghanem (L)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Melanie Balbach (M)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Navpreet Kaur (N)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Lonny R Levin (LR)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Jochen Buck (J)

Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Maria Kehr (M)

Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany.

Sandrine Coquille (S)

Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany.

Joop van den Heuvel (J)

Helmholtz Centre for Infection Research, Recombinant Protein Expression, Inhoffenstrasse 7, 38124 Braunschweig, Germany.

Clemens Steegborn (C)

Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany.

Makoto Fushimi (M)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

Efrat Finkin-Groner (E)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

Robert W Myers (RW)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

Stacia Kargman (S)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

Nigel J Liverton (NJ)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.

David J Huggins (DJ)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York 10021, United States.

Peter T Meinke (PT)

Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
Department of Pharmacology, Weill Cornell Medicine, New York, New York 10021, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH